Robert J. Palmisano
Director · AEON Biopharma, Inc.
Individual
- 2025
- Jun 22, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert J. Palmisano files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Timothy P. Lynch - $243K in AEON purchases and sales in the last 12 months
- Mark Wilterding - $54K in RXST purchases and sales in the last 12 months
- Ronald M. Md Kurtz - $35K in RXST purchases and sales in the last 12 months
- Ilya Goldshleger - $14K in RXST purchases and sales in the last 12 months
- Eric Weinberg - $14K in RXST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert J. Palmisano?
Robert J. Palmisano is a corporate insider, tracked as Director of AEON Biopharma, Inc. (AEON). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Robert J. Palmisano last file a Form 4?
The most recent primary Form 4 on record is dated 22 June 2026, one of 4 filings going back to 2025.
